| Name |
Tritace 1,25 mg tablete |
| Marketing Authorisation Number |
HR-H-251741808 |
| Active Substance |
ramipril |
| Composition |
jedna tableta sadržava 1,25 mg ramiprila |
| Pharmaceutical Form |
tableta |
| Manufacturer |
sanofi-Aventis S.r.l., Scoppito (L'Aquila), Italija |
| Marketing Authorisation Holder |
Sanofi Winthrop Industrie, 82, avenue Raspail, Gentilly, Francuska |
| Marketing Authorisation Date |
01.09.2023 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/14-02/144 |
| Registration Number |
381-12-01/286-23-57 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ponovljivi recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
C09AA05 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
